Roundtable Discussion: Establishing Clinically Meaningful EEG Signatures in Neuropsychiatry
2:30 pm - Tuesday 15th September 2026
- Which neuropsychiatric patient populations currently show the strongest evidence for EEG-based stratification?
- What have we learned from recent efforts to establish normative EEG datasets and biomarkers across depression, schizophrenia, sleep disorders and anxiety?
- Where are EEG biomarkers already influencing patient selection, dose rationale or efficacy assessment in clinical trials?
- What are the biggest barriers to regulatory acceptance and broader adoption of EEG endpoints?
- How should we combine EEG, digital biomarkers and clinical measures to advance precision neuropsychiatry?